Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?

被引：0
|
作者：
Choi, Jonggi [1 ]
Choi, Won-Mook [1 ]
Lim, Young-Suk [1 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88, Olymp Ro 43-gil, Seoul 05505, South Korea
来源：
CLINICS IN LIVER DISEASE | 2023年 / 27卷 / 04期
关键词：
Lamivudine; Adefovir; Entecavir; Tenofovir; Hepatitis B; Hepatocellular carcinoma; CHRONIC HEPATITIS-B; TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; DOUBLE-BLIND; ANTIVIRAL THERAPY; VIRUS INFECTION; ENTECAVIR; ALAFENAMIDE; RESISTANCE; PHASE-3;
D O I：
10.1016/j.cld.2023.05.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：809 / 818
页数：10
相关论文
共 50 条
  • [21] 2′-β-Methylselenyl nucleos(t)ide analogs as reverse transcriptase inhibitors against diverse HIV mutants
    Yoshida, Yuki
    Niimi, Yushi
    Fushihara, Daichi
    Katakura, Hideo
    Fukui, Ryusuke
    Murase, Hirotaka
    Tomoike, Fumiaki
    Hashiya, Fumitaka
    Murakami, Tsutomu
    Kodama, Eiichi N.
    Suzuki, Tetsuro
    Yasukawa, Kiyoshi
    Kimura, Yasuaki
    Abe, Hiroshi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 110
  • [22] THE IMPACT OF NUCLEOS(T)IDE ANALOGUES ON THE WAITING LIST
    Battistella, S.
    D'Arcangelo, F.
    Grasso, M.
    Zanetto, A.
    Gambato, M.
    Germani, G.
    Senzolo, M.
    Cillo, U.
    Vitale, A.
    Burra, P.
    Russo, F. P.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S165 - S165
  • [23] High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Lin, Ching-Chung
    Bair, Ming-Jong
    Liu, Chia-Yuan
    Lin, Ze-Yu
    Chen, Chih-Jen
    Chen, Ming-Jen
    Chu, Cheng-Hsin
    Wang, Horng-Yuan
    Shih, Shou-Chuan
    Wang, Tsang-En
    MEDICINE, 2019, 98 (01) : E13818
  • [24] Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition?
    Mehta, Neil
    Yao, Francis Y.
    HEPATOLOGY, 2016, 63 (05) : 1415 - 1417
  • [25] Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes
    Shimizu, Ryogo
    Murai, Kazuhisa
    Tanaka, Kensuke
    Sato, Yuga
    Takeda, Naho
    Nakasyo, Saki
    Shirasaki, Takayoshi
    Kawaguchi, Kazunori
    Shimakami, Tetsuro
    Nio, Kouki
    Nakaya, Yuki
    Kagiwada, Harumi
    Horimoto, Katsuhisa
    Mizokami, Masashi
    Kaneko, Shuichi
    Murata, Kazumoto
    Yamashita, Taro
    Honda, Masao
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (01)
  • [26] Nucleos(t)ide analogs reduces hepatocellular carcinoma mortality in patients with low HBV-DNA levels
    Wang, Xinhui
    Liu, Xiaoli
    Yu, Lihua
    Wang, Peng
    Jiang, Yuyong
    Wang, Xian-Bo
    Yang., ZhiYun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S912 - S913
  • [27] EVOLUTION OF HBV MULTIPLE DRUG-RESISTANT STRAINS IN A PATIENT RECEIVING SEQUENTIAL NUCLEOS(T)IDE ANALOGS
    Liu, Yan
    Wang, Chunmei
    Zhong, Yanwei
    Wang, Yao
    Chen, Li
    Li, Xiaodong
    Dai, Jiuzeng
    Ji, Dong
    Xu, Dongping
    HEPATOLOGY, 2009, 50 (04) : 516A - 516A
  • [28] DETECTION OF MUTATIONS ASSOCIATED WITH RESISTANCE TO NUCLEOS(T)IDE ANALOGS IN PATIENTS WITH HBV INFECTION DURING TREATMENT WITH TENOFOVIR
    van Boemmel, Florian
    Feucht, Heinz-Hubert
    Schlosser, Beate
    Weich, Viola
    Schott, Eckart
    Wiedenmann, Bertram
    Berg, Thomas
    HEPATOLOGY, 2008, 48 (04) : 715A - 716A
  • [29] Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
    Sonneveld, Milan J.
    Janssen, Harry L. A.
    LIVER INTERNATIONAL, 2011, 31 : 78 - 84
  • [30] PORTAL HYPERTENSION BUT NOT HCC RISK IS ATTENUATED IN COMPENSATED CIRRHOTICS FOLLOWING 10 YEARS OF TREATMENT WITH NUCLEOS(T)IDE ANALOGS
    Invernizzi, F.
    Lampertico, P.
    Mangia, G.
    Iavarone, M.
    Vigano, M.
    Primignani, M.
    De Franchis, R.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S429 - S430
12345